A B S T R A C T Catecholamines have several physiological effects on the kidney. These include: (a) stimulation of renin synthesis in the cortex; (b) antidiuresis by beta adrenergic agents; and (c) diuresis by alpha adrenergic stimulation. The role of cyclic 3',5'-adenosine monophosphate (cyclic AMP) in the renal actions of catecholamines was evaluated by measuring the effects of several adrenergic agents on cyclic AMP concentration in the dog kidney.
INTRODUCTION
Catecholamines are thought to effect, either directly or by interaction with other hormones, the generation of cyclic 3',5'-adenosine monophosphate (cyclic AMP)1 in several tissues (1, 2) . In the kidney, it has been sugReceived for publication 10 June 1971 and in revised form 29 October 1971. 1 Abbreziations used in this paper: 5'-AMP, 5'-adenosine monophosphate; cyclic AMP, cyclic 3',5'-adenosine monophosphate; PGE1, prostaglandin E- 1. gested that catecholamines stimulate renin secretion (3) (4) (5) . Michelakis, Caudle, and Liddle (6) demonstrated that both exogenous cyclic AMP and catecholamines, when added to renal cortical slices in vitro, stimulate renin synthesis. They suggested that catecholamines augment renin synthesis by stimulating cyclic AMP generation in the renal cortex. Additionally, it has been shown that beta adrenergic stimuli induce an antidiuretic effect by unknown mechanisms (7) (8) (9) , and that alpha-adrenergic stimuli cause a diuresis by inhibiting the effect of vasopressin to increase membrane permeability (8) (9) (10) . In support of this latter concept Handler, Bensinger, and Orloff (11) demonstrated that alpha adrenergic agents inhibit the hydro-osmotic effect of vasopressin, but not of exogenous cyclic AMP. On the basis of these observations, they proposed that alpha adrenergic activity inhibits the effect of vasopressin to stimulate cyclic AMP generation.
In this study these hypotheses were evaluated by investigating the effect of catecholamines alone and in combination with other hormones on cyclic AMP concentration in dog kidney.
METHODS
Mongrel dogs, weighing [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] kg, were anesthetized with Nembutal (Abbott Laboratories, North Chicago, Ill.), and the kidneys were removed rapidly and kept in ice-cold KrebsRinger bicarbonate buffer during the following procedures. The cortex, the red outer medulla, and the white inner medulla were studied separately.
Cyclic AMP conlcentration . The kidney tissues were sliced to a thickness of less than 0.5 mm. Each slice was then divided into the appropriate number of smaller slices with a weight of 40-120 mg. The slices were incubated as appropriate pairs for 15 min at 37'C in Krebs-Ringer bicarbonate buffer containing 102 M theophylline, and gassed with 5%o CO2 and 95% 02. The study substances were added to the incubation media as indicated in the Results section. After the incubation, the slices were homogenized in 5% trichloro-acetic acid with glass homogenizer, and centrifuged at 700 g for 15 min.
Cyclic AMP was assayed using a modification of Gilman's method (12) . In summary, the supernates of the homogenized tissue were mixed with the equal volume of 1 N sodium acetate, pH 12, which brought the final pH of the mixture to pH 5. Then, 0.5 pmoles of cyclic AMP-8H (specific activity 14.2 Ci/mmole), a mixture of cyclic AMP-binding protein and protein kinase inhibitor was added in proper dilution. They were then incubated at 4'C in a refrigerator for 60 min. After the incubation, the free unbound cyclic AMP was separated from the protein-bound cyclic AMP uisng dextran-coated charcoal as described by Herbert, Lau, Gettlieb, and Bleicher (13) . The samples were counted in a liquid scintillator. All assays were performed in triplicate. The standard curve in the range of 1.5-100 pmoles of cyclic AMP was simultaneously obtained in each series of assay. In this range, the standard cyclic AMP curve was linear, and the assayed tissue cyclic AMP were always in that range.
Cyclic AMP-binding protein was prepared as described by Miyamoto, Kuo, and Greengard (14) . Bovine heart muscle was used and was purified to the steps of acid precipitation and ammonium sulfate fractionation. Each batch of cyclic AMP-binding protein was titrated to have the proper dilution to bind 20-30% of cyclic AMP-'H in the assay. Protein kinase inhibitor was prepared as described by Gilman (12) , and its activity titrated each time to determine the maximal inhibitory effect.
The recovery rate of cyclic AMP after the entire tissue extraction procedures, measured with cyclic AMP-8H as a tracer, was 76.85% with a standard deviation of 1.90%.
These data indicate a constant recovery rate.
Cyclic nucleotide phosphodiesterase. Cyclic AMP phosphodiesterase was prepared as described by Cheung (15 These results indicate that alpha adrenergic stimulus has no effect on cyclic AMP concentration, but beta adrenergic agents stimulate cyclic AMP generation in all three parts of the kidney.
Effects of catecholamines on cyclic AMP phosphodiesterase activity. As shown in Table III , epinephrine 10' M (both alpha and beta adrenergic activity) had no measurable effect on phosphodiesterase activity in either the cortex or the inner medulla; the control of 542 +SE 4 pmoles of cyclic AMP converted to 5'-AMP/ mg of protein per min, and 548 ±2 with the addition of epinephrine in the cortex; and the control of 1756 ±9, and 1765 ±7 with addition of epinephrine in the inner medulla. Neither did the addition of either propranolol 10' M (beta adrenergic blockade) or phentolamine 10-' M (alpha adrenergic blockade) with epinephrine have any effect on phosphodiesterase activity. The 544 ±2 and 1,763 ±10 in cortex and inner medulla with the addition of propranolol and epinephrine (alpha adrenergic effect only); and the 531 ±6 and 1,726 ±17 with the addition of phentolamine and epinephrine (beta adrenergic effect only), were not measurably different than controls.
Theophylline 10' M inhibited phosphodiesterase activity to 335 ±2 from the control of 542 ±2 in the cortex, and to 762 +17 from the control of 1756 ±9 in the inner medulla, P < 0.001 each. However, the values with the (6) Epinephrine 10-6 M 548 ±2 (4) 1765 ±7 (6) Epinephrine 10-6 M + propranolol 10-4 M 544 ±2 (4) 1763 ±10 (6) Epinephrine 10-6 M + phentolamine 10-4 AI 531 ±6 (4) 1726 417 (6) Theophylline 10-2 M 335 ±2 (4) 762 ±17 (6) Theophylline 10-2 M + epinephrine 10-6 M 311 ±11 (4) 790 ±37 (6) Theophylline 10-2 M + epinephrine 10-6 M + propranolol 10-4 M 342 i 14 (4) 852 ±55 (6) * Mean i±SEM. (6) Vasopressin 10-i U/ml 1.53 ±0.20 (6) Vasopressin 10-3 U/ml + propranolol 10-4 M 1.56 ±0.20 (6) * Mean ±SE.
$ Within the parenthesis are the numbers of observations. addition of epinephrine 10' M alone (311 ±11 in the cortex, and 790 +37 in the inner medulla, and with the combination of the epinephrine and propranolol 10' M (342 ±14 in the cortex, and 852 +55 in the inner medulla) to theophylline 102 M, were not different from theophylline alone, Table III . These results indicate that catecholamines have no effect on cyclic AMP phosphodiesterase. Neither do they interact with theophylline to inhibit phosphodiesterase activity.
Interaction of catecholamines and vasopressin on cyclic AMP concentration. A submaximal dose of vasopressin (Pitressin; Parke, Davis & Co., Detroit, Mich.) 10' U/ml (18) increased cyclic AMP concentration from the control of 1.42 ±0.12 to 2.35 ±0.14 in the inner medulla, P < 0.001, Table IV . An alpha adrenergic stimulus obtained by the combination of epinephrine 10' M and propranolol 10-' M, decreased vasopressin effect to 1.98 ±0.15, (P < 0.05). In a separate series, the effect of propranolol 10' M per se on vasopressin was evaluated. As shown in Table IV , vasopressin 10-' U/ml increased cyclic AMP concentration in the inner medulla from the control of 0.63 ±0.14 to 1.53 ±0.20 (P < 0.001). The addition of propranolol 10' M alone to vasopressin had the value of 1.56 ±0.20 which is not measurably different from that of vasopressin alone. These data suggest that the inhibitory effect on vasopressin is not from propranolol, but rather from the alpha adrenergic activity of epinephrine.
Effects of alpha adrenergic stimuli on other hormones. As shown in Table V , parathyroid hormone 1 U/ml increased cyclic AMP concentration in the cortex from the control of 0.36 +0.02 to 0.97 +0.13, P < 0.01. The addition of an alpha adrenergic effect by the combination of epinephrine 10' M and propranolol 10-' M along with parathyroid hormone also increased the value to 0.87 + 0.09, not measurably different from the value of parathyroid hormone alone.
Prostaglandin E-1 (PGE1) 10' M increased cyclic AMP concentration in the inner medulla, from the control of 1.38 ±0.15 to 2.56 40.39, P < 0.001. The addition of an alpha adrenergic stimulus to prostaglandin E-1 did not measurably change the effect of PGE1 alone, Table II , norepinephrine increased cyclic AMP concentration. This is increase in cyclic AMP concentration induced by norepinephrine could be due to the fact that it also exerts a beta adrenergic effect in this system. Effects of theophylline. As shown in Figure 1 , theophylline 10-' M was the lowest concentration to inhibit cyclic AMP phosphodiesterase activity significantly: (3) (4) (5) . Michelakis et al. (6) proposed that catecholamine stimulates renin synthesis, mediated by cyclic AMP. This hypothesis was on the basis of their observation that catecholamine in the incubation media increased renin synthesis in tissue slices of dog renal cortex; and exogenous cyclic AMP also increased renin synthesis. Our observation of the induction of an increase in cyclic AMP concentration in the renal cortex by beta adrenergic stimulation is consistent with the Michelakis hypothesis.
Beta adrenergic stimuli have an antidiuretic effect similar to vasopressin both in intact and denervated kidneys (7) . These results show that beta adrenergic agents, like vasopressin, increase cyclic AMP concentration in the outer and the inner medullae. This finding is consistent with the hypothesis that beta adrenergicinduced antidiuresis is mediated by increasing cyclic AMP concentration in the renal medulla.
Conversely, alpha adrenergic agents have been demon-
